The price of Cigna Corporation (NYSE: CI) closed at $310.66 in the last session, up 0.75% from day before closing price of $308.36. In other words, the price has increased by $+2.30 from its previous closing price. On the day, 1207622 shares were traded. CI stock price reached its highest trading level at $313.75 during the session, while it also had its lowest trading level at $309.24.
We take a closer look at CI’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.25 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.43. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.62.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on January 03, 2023, Downgraded its rating to Equal Weight and sets its target price to $355 from $370 previously.
Raymond James Downgraded its Strong Buy to Outperform on November 21, 2022, while the target price for the stock was maintained at $370.
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 16 when Ryan Cynthia sold 3,009 shares for $327.95 per share. The transaction valued at 986,802 led to the insider holds 4,319 shares of the business.
Sadler Jason D sold 16,667 shares of CI for $5,564,763 on Dec 08. The Pres., International Markets now owns 35,750 shares after completing the transaction at $333.88 per share. On Oct 14, another insider, Palmer Eric P, who serves as the President & CEO, Evernorth of the company, sold 4,000 shares for $300.00 each. As a result, the insider received 1,200,004 and left with 36,838 shares of the company.
As of this moment, Cigna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.84, and their Forward P/E ratio for the next fiscal year is 12.51. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.29. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.52 while its Price-to-Book (P/B) ratio in mrq is 2.10.
Stock Price History:
Over the past 52 weeks, CI has reached a high of $340.11, while it has fallen to a 52-week low of $213.16. The 50-Day Moving Average of the stock is 321.45, while the 200-Day Moving Average is calculated to be 286.94.
According to the various share statistics, CI traded on average about 1.74M shares per day over the past 3-months and 1.8M shares per day over the past 10 days. A total of 303.85M shares are outstanding, with a floating share count of 300.92M. Insiders hold about 0.10% of the company’s shares, while institutions hold 91.60% stake in the company. Shares short for CI as of Oct 13, 2022 were 4.06M with a Short Ratio of 3.13M, compared to 4.6M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 1.33% and a Short% of Float of 1.34%.
Dividends & Splits
The forward annual dividend rate for CI is 4.48, which was 0.04 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.01%, it implies a Forward Annual Dividend Yield of 1.42%. The stock’s 5-year Average Dividend Yield is 0.42. The current Payout Ratio is 20.60% for CI, which recently paid a dividend on Dec 20, 2022 with an ex-dividend date of Dec 04, 2022. Stock splits for the company last occurred on Jun 04, 2007 when the company split stock in a 3:1 ratio.
The company has 18 analysts who recommend its stock at the moment. On average, analysts expect EPS of $5.71 for the current quarter, with a high estimate of $6.07 and a low estimate of $5.56, while EPS last year was $5.73. The consensus estimate for the next quarter is $5.04, with high estimates of $5.21 and low estimates of $4.75.
Analysts are recommending an EPS of between $23.25 and $22.86 for the fiscal current year, implying an average EPS of $23. EPS for the following year is $25.32, with 22 analysts recommending between $25.85 and $24.5.
According to 18 analysts, the current quarter’s revenue is expected to be $44.76B. It ranges from a high estimate of $45.88B to a low estimate of $43.55B. As of the current estimate, Cigna Corporation’s year-ago sales were $42.92B, an estimated increase of 4.30% from the year-ago figure. For the next quarter, 18 analysts are estimating revenue of $45.75B, an increase of 0.20% less than the figure of $4.30% in the same quarter last year. There is a high estimate of $47.21B for the next quarter, whereas the lowest estimate is $44.74B.
A total of 20 analysts have provided revenue estimates for CI’s current fiscal year. The highest revenue estimate was $182.58B, while the lowest revenue estimate was $177.15B, resulting in an average revenue estimate of $179.85B. In the same quarter a year ago, actual revenue was $174.08B, up 3.30% from the average estimate. Based on 18 analysts’ estimates, the company’s revenue will be $188.71B in the next fiscal year. The high estimate is $192.74B and the low estimate is $182.91B. The average revenue growth estimate for next year is up 4.90% from the average revenue estimate for this year.